Inactive Instrument

Transcripts MORPHOSYS Swiss Exchange

Equities

OXMOR

DE0006632003

Real-time Estimate Tradegate Other stock markets 02:28:55 2024-05-15 am EDT			5-day change	1st Jan Change
67.82 ^EUR	0.00%		0.00%	0.00%

May. 06	MORPHOSYS : UBS reiterates its Neutral rating	ZD
Apr. 30	European Equities Traded in the US as American Depositary Receipts Decline	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : MorphoSys AG, 2023 Earnings Call, Mar 14, 2024	Mar. 14
Transcript : MorphoSys AG, Novartis AG - M&A Call	Feb. 06
Transcript : MorphoSys AG Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:00 PM	Jan. 10
Transcript : MorphoSys AG - Special Call	Dec. 11
Transcript : MorphoSys AG - Special Call	Nov. 21
Transcript : MorphoSys AG, Q3 2023 Earnings Call, Nov 16, 2023	Nov. 16
Transcript : MorphoSys AG Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 02:55 PM	23-09-13
Transcript : MorphoSys AG, Q2 2023 Earnings Call, Aug 10, 2023	23-08-10
Transcript : MorphoSys AG - Special Call	23-06-21
Transcript : MorphoSys AG Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-13-2023 02:40 PM	23-06-13
Transcript : MorphoSys AG, Q1 2023 Earnings Call, May 04, 2023	23-05-04
Transcript : MorphoSys AG, 2022 Earnings Call, Mar 16, 2023	23-03-16
Transcript : MorphoSys AG Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 05:15 PM	23-01-11
Transcript : MorphoSys AG, Q3 2022 Earnings Call, Nov 17, 2022	22-11-17
Transcript : MorphoSys AG Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 09:10 AM	22-09-13
Transcript : MorphoSys AG, H1 2022 Earnings Call, Aug 04, 2022	22-08-04
Morphosys Ag Updates Monjuvi U.S. Net Product Sales Guidance for the Year 2022	22-07-26	CI
MorphoSys AG Confirms Financial Guidance for the Year 2022	22-06-23	CI
Transcript : MorphoSys AG, Q1 2022 Earnings Call, May 05, 2022	22-05-05
MorphoSys AG Reiterates Monjuvi U.S. Net Product Sales Guidance for the Year 2022	22-05-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts MORPHOSYS Swiss Exchange

Equities

OXMOR

DE0006632003

Transcripts

Filters